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Considering that a set of three genes is sufficient for the 
replication of most retroviruses, the human and simian 
immunodeficiency viruses (HIV and SIV) exhibit a surpris- 
ing degree of genomic complexity. HIV-1 contains no less 
than six open reading frames in addition to the prototypic 
gag, pol, and env coding sequences (see Figure 1). Two 
of these supplementary genes, tatand rev, are absolutely 
necessary for virus growth: Tat is a major transactivator 
of the proviral long terminal repeat (LTR), and Rev acts 
posttranscriptionally to ensure th switch from the early 
to the late phase of viral gene expression. In contrast, nef, 
vpu, vif, vpr, and the HIV-2 and SIV vpx genes encode 
factors that are dispensable for virus growth in many in 
vitro systems and are thus commonly called accessory 
proteins. Nevertheless, the high degree of conservation 
of these products indicate that they fulfill crucial functions 
in vivo. Exciting new studies are shedding light on these 
functions and reveal surprising interactions between HIV 
and its host cell. 
Nef: Negative Only for the Host 
Nef is encoded only by primate lentiviruses and is pro- 
duced at all stages of viral gene expression. A predomi- 
nantly cytoplasmic protein that associates with the plasma 
membrane through an N-terminal myristate, Nef was first 
suspected to repress transcription from the LTR, hence its 
acronym for "negative factor." However, studies in rhesus 
monkeys infected with nef-deleted strains of SIV demon- 
strated that this protein is necessary for high titer replica- 
tion of SIV in vivo and for AIDS induction (Kestler et al., 
1991). This can be explained by at least three effects of
Nef: the induction of CD4 down-regulation, the alteration 
of T cell activation pathways, and the enhancement of 
virus infectivity. 
Nef triggers the rapid endocytosis and lysosomal degra- 
dation of CD4, the main virus receptor (Aiken et al., 1994). 
A number of other cell surface molecules are not affected, 
ruling out a nonspecific stimulation of endocytosis. Instead, 
when 20 membrane-proximal residues from the CD4 cyto- 
plasmic domain, including a critical dileucine-based sort- 
ing signal, are transferred to CD8, the resulting chimera 
becomes Nef responsive. Several models can thus be pro- 
posed. Nef could modify CD4 so that the receptor dileucine 
motif becomes accessible to clathrin-coated pits, the me- 
diators of CD4 endocytosis. This would be reminiscent 
of CD4 response to phorbol esters, although t e latter 
process involves phosphorylation of the receptor, a modifi- 
cation not triggered by Nef. Alternatively, Nef might liber- 
ate CD4 from an anchor that normally prevents its recruit- 
ment into coated pits. The lymphoid-specific p56~k tyrosine 
kinase bound to the CD4 cytoplasmic tail plays such an 
inhibitory role. While Lck is released by Nef, this seems 
to be an epiphenomenon, because Nef-induced CD4 
down-modulation is observed in cells that do not express 
Lck and on truncated CD4 molecules that do not bind the 
kinase. In yet another model that would be unprecedented, 
Nef could physically connect CD4 with a component of 
the internalization pathway. Future experiments should 
test these various possibilities, in particular bydetermining 
conclusively whether Nef, directly or indirectly, interacts 
with CD4 or with the endocytic apparatus. Irrespective of 
its mechanism, what' advantage does Nef-mediated CD4 
down-regulation confer to the virus? Does it rapidly block 
detrimental superinfection events? Does it prevent virus 
aggregation on the surface of cells during budding, analo- 
gous to the role played by neuraminidase for influenza 
virus? Or does it indirectly enhance viral gene expression 
through an alteration of T cell activation pathways, for in- 
stance by increasing the levels of free Lck? 
T cell activation is perturbed by Nef, but different experi- 
mental settings have yielded conflicting results. Defective 
NF-KB induction and interleukin-2 (IL-2) expression were 
reported in Jurkat cells stably producing Nef, whereas an 
elevated signaling was observed in other c llular contexts, 
including thymocytes from nef transgenic mice (Luria et
al., 1991 ; Niederman et al., 1992; Skowronski et al., 1993). 
In a recent study, expression f a chimeric CD8-Nef mole- 
cule in Jurkat cells induced two opposite phenotypes, 
which depended on the intracellular location of the fusion 
protein (Baur et al., 1994). In most cells, the chimera accu- 
mulated in the cytoplasm, and this was associated with a 
block in the early events of T cell signaling through the T 
cell receptor (TCR). In contrast, cells selected for their 
high surface levels of CD8-Nef showed spontaneous acti- 
vation, which led to apoptosis. These results could be ex- 
plained if Nef binds a cellular protein involved in activation. 
When kept in the cytoplasm, Nef would sequester the puta- 
tive signaling molecule away from the TCR; when translo- 
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cated to the cell surface, Nef and its associated protein 
would induce activation. 
A third demonstrated function of Nef is the so-called 
enhancement of HIV-1 infectivity (Miller et al., 1994; Spina 
et al., 1994). Independent of CD4 down-regulation, both 
functionally and genetically, this effect is exerted at the 
stage of virus particle formation, yet manifested only after 
the virus enters target cells. Recent results suggest that 
it might reflect a stimulation of proviral DNA synthesis 
(Schwartz et al., 1995). Since only minimal amounts of 
Nef are detected in particles, the protein must act through 
an intermediate, for instance a component of the reverse 
transcription complex. Interestingly, the phenotype of nef- 
defective HIV-1 is best revealed when peripheral blood 
lymphocytes (PBL) are infected prior to stimulation. Is it 
because reverse transcription is already inefficient in rest- 
ing T cells (Zack et al., 1990), or because Nef also influ- 
ences activation? 
Understanding the mechanisms of Nef action will re- 
quire the identification of its cellular partners. Two distinct 
families of protein kinases are among the strongest candi- 
dates. First, a cellular serine kinase can be immunoprecip- 
itated with Nef, together with proteins that undergo phos- 
phorylation in an in vitro kinase assay (Sawai et al., 1994). 
The nature of the protein kinase and of its substrate(s), 
as well as the functional significance of their interaction 
with Nef, remain to be determined. Second, the Src homol- 
ogy region 3 (SH3) domains of Hck and Lyn show specific 
binding to a conserved (PxxP) repeat in Nef, correspond- 
ing to the minimal consensus site for SH3-mediated pro- 
tein-protein interactions (Saksela et al., 1995). A func- 
tional role for this type of interaction is suggested by the 
finding that a PxxP-mutated nef allele is still competent 
for CD4 down-regulation, yet fails to enhance HIV-1 repli- 
cation in PBL infected prior to stimulation. Further charac- 
terization of the intricate network connecting Nef with cel- 
lular pathways is warranted. 
Vpu" Dual Overdrive 
A late viral gene product translated from a bicistronic 
mRNA that also contains the env open reading frame, Vpu 
(viral protein U) is expressed by most HIV-1 isolates but 
not by HIV-2 or SIV, with the notable exception of SIVcpz, 
a close relative of HIV-I. Vpu is an integral membrane 
phosphoprotein that associates mainly with the internal 
membranes of the cell, apparently in an oligomeric form 
(Maldarelli et al., 1993). Vpu carries a dual function, down- 
modulating CD4 and enhancing virion release. 
In HIV-infected cells, intracellular complexes between 
CD4 and the viral envelope form in the endoplasmic reticu- 
lum (ER), trapping both proteins in this compartment. Vpu 
interacts with the cytoplasmic domain of ER-retained CD4 
molecules and triggers their accelerated degradation 
(Willey et al., 1992b; Bour et al., 1995). The mechanism 
of this process is still obscure, although it likely involves 
proteolytic pathways utilized by cells to eliminate proteins 
that fail to fold correctly or to assemble into proper oligo- 
meric complexes, such as observed with the components 
of the TCR. By analogy, Vpu could induce aggregation or 
some other structural change of CD4, thus exposing the 
receptor to the ER degradative pathway. Vpu-induced 
CD4 down-modulation enhances the intracellular trans- 
port and maturation of Env (Willey et al., 1992a). This is 
predicted to increase the infectivity of HIV-1 virions, per- 
haps mostly for cells expressing low levels of the virus 
receptor, such as macrophages. This point remains to be 
formally demonstrated. 
Vpu also stimulates the release of virions from the sur- 
face of infected cells. This effect is both functionally and 
genetically distinguishable from CD4 down-regulation. For 
instance, the promotion of virus release can occur in the 
absence of Env and CD4. Also, it does not require Vpu 
phosphorylation but is blocked when the protein is retained 
in the ER, whereas the inverse is true of CD4 down- 
modulation (Schubert and Strebel, 1994). Curiously, Vpu 
also stimulates the budding of retroviruses that lack a Vpu- 
like activity, such as HIV-2, visna virus, and murine leuke- 
mia virus (GSttlin ger et al., 1993). This raises the possibility 
that Vpu might alter a common intracellular pathway that 
is followed by different retroviral Gag proteins. The nature 
of this pathway is unknown. 
An intriguing structural homology was noted between 
Vpu and the M2 protein of influenza, whose capacity as an 
ion channel seems to regulate the pH of some intracellular 
compartments. Whether one of the effects of Vpu is associ- 
ated with a similar type of activity awaits demonstration. 
Vif: Essential yet Elusive 
Vif (virion infectivity factor) is a late gene product present 
in most lentiviruses that acts during assembly to allow 
the formation of particles competent for the early steps of 
infection (Gabuzda et al., 1992; von Schwedler et al., 
1993). This effect is probably indirect, because only traces 
of the protein are found in virions, vif-mutated HIV-1 effi- 
ciently produces viral particles, but these exhibit an im- 
properly packed nucleoprotein core (H6glund et al., 1994) 
and fail to synthesize the proviral DNA in target cells (von 
Schwedler et al., 1993). Whether this phenotype primarily 
reflects a decreased stability of the reverse transcription 
complex, an impaired uncoating of the internalized virion, 
or an abnormal entry process is still a matter of debate 
(von Schwedler et al., 1993; Borman et al., 1995). The Vif 
requirement is strictly cell dependent and, furthermore, 
determined solely by the cells releasing the virions, not 
by the targets of the infection, vif-mutated HIV-1 is thus 
functionally impaired only if produced from PBL, macro- 
phages, and some rare T lymphoid cell lines such as H9. 
The restrictiveness of primary cells corroborates the fail- 
ure of vif-mutated SlVmao to replicate in vivo. Whether the 
permissiveness of other cells reflects the expression of a 
cellular homolog of Vif, or the absence of an inhibitor of 
virus replication ormally counteracted by the viral protein, 
remains to be determined. A complication resulting from 
the cell specificity of the vif-defective phenotype is that it 
is technically difficult o produce high titer stocks of func- 
tionally relevant virus. Identifying conditional mutants of 
vifor using controllable vifexpression systems could help 
solve this problem. Future investigations hould also aim 
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at characterizing the cellular or viral proteins that interact 
with Vif. Finally, one should ask what unique aspect of 
lentiviral replication explains that the presence of vif be 
limited to this group of retroviruses. 
Vpr: Manipulating the Cell 
Vpr (viral protein R) is encoded by HIV-1, HIV-2, and most 
SIV isolates. Vpr is a short basic protein that associates 
with viral particles through an interaction with the C-terminal 
region of Gag and accumulates in the nucleus of infected 
cells (Lu et al., 1993). Long in quest of a function, Vpr 
has now been recognized as a key to crucial interactions 
between the virus and its host cell. 
Oncoretroviruses depend on cell proliferation for their 
replication, because the breakdown of the nuclear enve- 
lope at mitosis allows the viral preintegration complex to 
interact with the host cell chromosomes. In contrast, HIV 
and other lentMruses can infect nondividing cells, a prop- 
erty essential for spreading in such critical targets as termi- 
nally differentiated macrophages. Together with the viral 
matrix (MA) protein, Vpr plays a fundamental role in this 
process by connecting the preintegration complex with 
the cell nuclear import pathway (Heinzinger et al., 1994). 
HIV-1 strains carrying mutations in both Vpr and the karyo- 
philic determinants of MA are thus unable to infect macro- 
phages or growth-arrested cells, owing to a block in nu- 
clear migration. In this context, the functions of MA and 
Vpr are redundant. However, the karyophilic motifs of 
these two proteins differ, suggesting that they govern viral 
nuclear import through the recognition of distinct cellular 
receptors. Such versatility would help ensure the comple- 
tion of a step critical for viral spread in vivo. Vpr/MA double 
mutants also cannot establish a stable infection intermedi- 
ate in quiescent T lymphocytes, indicating that this pro- 
cess too depends on the affinity of the preintegration com- 
plex for the nuclear transport apparatus (yon Schwedler 
et al., 1994). MA alone suffices to restore this property. 
Whether Vpr also plays a role in this setting is yet unde- 
fined. 
A puzzling discovery is that Vpr can perturb the cell 
cycle. HIV-1 vpr expression was first noted to induce 
growth arrest and differentiation in rhabdomyosarcoma 
and osteosarcoma cell lines (Levy et al., 1993). Recent 
experiments have indirectly confirmed these data, reveal- 
ing that Vpr produces an accumulation of cells in the G2 
phase of the cell cycle and, thereby, prevents the estab- 
lishment of chronic HIV-1 infection in T lymphocytes (Ro- 
gel et al., 1995). This is a counterintuitive event, but the 
loss of chronically infected T cells might not be an issue 
in vivo, since virus-producing T lymphocytes are rapidly 
eliminated anyway because of either Env-mediated cyto- 
pathicity or immune cytotoxic responses (Ho et al., 1995; 
Wei et al., 1995). The differentiating effect of Vpr might 
thus have beneficial consequences before this happens, 
or in nondividing cells such as macrophages. In that re- 
spect, Vpr has been shown to increase the permissiveness 
of cells to HIV transcription, albeit slightly (Cohen et al., 
1990). In one instance, it was reported to act in a paracrine 
manner, even when cells are exposed to a single dose of 
recombinant Vpr several days prior to infection (Levy et 
al., 1995). Confirming this observation and exploring fur- 
ther the mechanism of the Vpr-induced cell cycle arrest 
could provide important insights on basic events control- 
ling cell growth. 
It may seem surprising that vpr-defective SlVr, ac is as 
pathogenic as wild type in rhesus monkeys (Gibbs et al., 
1995). However, SIV and HIV-2 express vpx, whose se- 
quence presents striking homologies with that of vpr, sug- 
gesting a genetic duplication. Like Vpr, Vpx associates 
with virions through an interaction with the C-terminal re- 
gion of Gag (Wu et al., 1994). Furthermore, vpr-vpx dou- 
ble-mutant SIV replicates poorly in vivo and fails to induce 
disease (Gibbs et al., 1995). It will be interesting to investi- 
gate this possible overlap by testing whether Vpx also 
carries some of the recently discovered functions of Vpr. 
Concluding Remarks 
Accessory in name only, Nef, Vpu, Vif, and Vpr-Vpx are 
crucial determinants of HIV virulence. As such, these fac- 
tors represent potentially valuable targets for the treat- 
ment of HIV-induced disease. Developing methods to 
interfere with these proteins will require an exquisite un- 
derstanding of their mechanisms of action, the identifica- 
tion of their interlocutors in the cell, the creation of simple 
in vitro assays reflecting their activities, and ultimately, a
detailed knowledge of their three-dimensional structure. 
As a bonus, efforts aimed at meeting this challenge will 
likely be rewarded along the way by further discoveries 
on basic cellular processes. 
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